- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS-707035
Total 3179 results
-
Bristol-Myers SquibbCelgeneCompleted
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
InspireMDWithdrawnST Segment Elevated Myocardial InfarctionUnited Kingdom
-
Aegerion Pharmaceuticals, Inc.University of Pennsylvania; Doris Duke Charitable FoundationCompletedHomozygous Familial HypercholesterolemiaUnited States
-
Bristol-Myers SquibbCompletedAlzheimer's Disease
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Bristol-Myers SquibbCompletedHealthy | Hepatitis CUnited States, Puerto Rico
-
MedSIRMedical University of ViennaNot yet recruitingNSCLC | Brain Metastases | ROS1 Gene Rearrangement
-
CelgeneCompletedHealthy VolunteersUnited States
-
CelgeneTerminated
-
Bristol-Myers SquibbExelixisTerminatedMetastatic Cancer | Advanced Solid CancersUnited States, Canada, France
-
Bristol-Myers SquibbCompletedHeart FailureFrance, Germany, Japan, Spain, United States, Argentina, Poland, Italy, Czechia, Greece, Netherlands, Canada, United Kingdom
-
Aegerion Pharmaceuticals, Inc.CompletedFamilial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Vanda PharmaceuticalsCompletedHealthy VolunteersUnited States
-
InspireMDCompletedMyocardial InfarctionPoland, South Africa
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedGastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbWithdrawnHepatitis C VirusUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbCompletedHealthy Subjects and Atopic Dermatitis SubjectsUnited Kingdom
-
National Human Genome Research Institute (NHGRI)Recruiting
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
Ronald LevyBristol-Myers SquibbCompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Extracranial Solid NeoplasmUnited States
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Bristol-Myers SquibbCompletedHepatic ImpairmentUnited States
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic CavityUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Topokine Therapeutics, Inc.Completed
-
Janssen Research & Development, LLCBristol-Myers SquibbRecruitingAcute Coronary SyndromeUnited States, Taiwan, Korea, Republic of, Italy, South Africa, Belgium, Argentina, Israel, Malaysia, Romania, Serbia, China, Australia, Netherlands, United Kingdom, Denmark, Czechia, Hungary, Japan, France, Canada, Bulgaria, Spain, T... and more
-
Janssen Research & Development, LLCBristol Myers Squibb Company (BMS)RecruitingIschemic Stroke; Ischemic Attack, TransientItaly, United States, Hong Kong, Japan, Taiwan, South Africa, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Czechia, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Hungary, ... and more
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
R-PharmCompletedMetastatic Pancreatic CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Worldwide Clinical TrialsTerminatedPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus SyndromeUnited States, Australia, Italy, Spain
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Limerick BioPharmaUnknownInsulin Resistance | Impaired Glucose ToleranceUnited States